First-in-Human Study of [(211)At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial)
首次人体研究:[(211)At]NaAt 作为靶向 α 疗法治疗放射性碘难治性甲状腺癌患者(Alpha-T1 试验)
期刊:
影响因子:
doi:10.2967/jnumed.125.270810
Watabe, Tadashi; Mukai, Kosuke; Naka, Sadahiro; Sasaki, Hidetaka; Kamiya, Takashi; Hayakawa, Tomoaki; Fukuhara, Atsunori; Takano, Toru; Shirakami, Yoshifumi; Ooe, Kazuhiro; Shigeno, Satoshi; Okamura, Satomi; Masumura, Kazuho; Hida, Eisuke; Haba, Hiromitsu; Toyoshima, Atsushi; Isohashi, Kayako; Shimomura, Iichiro; Tomiyama, Noriyuki